TypeZero (Artificial Pancreas Technology) is Buildings and Property in United States that focus on monitoring platform business. They cover business area such as diabetes, monitoring platform, blood glucose level, smartphone application, correction, blood sugar level, an integrate insulin pump.
-
Monitoring Platform
-
919 Second Street SouthEast
Charlottesville, VA 22902
United States
Private
diabetesmonitoring platformblood glucose levelsmartphone applicationcorrectionblood sugar levelan integrate insulin pump
* We use standard office opening hours in near TypeZero (Artificial Pancreas Technology)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TypeZero (Artificial Pancreas Technology) is Buildings and Property business from United States that founded in - ( years old in ), TypeZero (Artificial Pancreas Technology) business is focusing on Monitoring Platform.
TypeZero (Artificial Pancreas Technology) headquarter office and corporate office address is located in 919 Second Street SouthEast Charlottesville, VA 22902 United States.
TypeZero (Artificial Pancreas Technology) was founded in United States.
In , TypeZero (Artificial Pancreas Technology) is currently focus on monitoring platform sector.
Above is snippet of Google Trends for "monitoring platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TypeZero (Artificial Pancreas Technology), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.